- Global Pharma News & Resources

Press Releases - 2019-12-19

Date Title Company
19-Dec-2019 Express Scripts and Prime Therapeutics Collaborate to Deliver More Affordable Care to More than 100 Million Americans Prime Therapeutics LLC
19-Dec-2019 IRRAS Receives Renewed CE Mark for the IRRAflow Catheter IRRAS
19-Dec-2019 Expedeon AG: Expedeon shareholders approve sale of proteomics & immunotherapy business and name change to 4basebio AG (news with additional features) Expedeon AG
19-Dec-2019 HumanOptics AG: Person of Chinese investor now known as indirect majority shareholder of HumanOptics AG HumanOptics AG
19-Dec-2019 Large Real-World Data Confirm Safety and Effectiveness of LIXIANA®▼ (edoxaban) in Routine Clinical Practice for Elderly AF Patients with Comorbidities Daiichi Sankyo Europe GmbH
19-Dec-2019 Sanofi wins prestigious drug discovery award for innovative rare blood clotting disorder treatment Sanofi UK
19-Dec-2019 Hackensack Meridian Health and Georgetown Lombardi Comprehensive Cancer Center Become Associate Members of the New York Genome Center New York Genome Center
19-Dec-2019 Bayer receives FDA clearance for expanded use of MEDRAD® Stellant FLEX CT Injection System in Contrast Enhanced Mammography (CEM) Bayer
19-Dec-2019 StemoniX to Present at Biotech Showcase 2020 StemoniX
19-Dec-2019 BC Platforms Closes $15 million Series C Financing and Signs Partnership with IQVIA to Extend Data Analytics in Genomics BC Platforms
19-Dec-2019 Nordic Nanovector awarded NOK 12 million in funding from the Norwegian Research Council to advance Alpha37, a targeted alpha therapy for B-cell cancers Nordic Nanovector ASA
19-Dec-2019 Cambridge Semantics Expands to Australia and New Zealand Cambridge Semantics
19-Dec-2019 World first treatment with ‘acoustic cluster therapy’ to improve chemotherapy delivery The Institute of Cancer Research, London,
19-Dec-2019 KNOW Bio Announces Acquisition of Clinical Sensors, Inc. KNOW Bio, LLC
19-Dec-2019 Nobel Prize winning research prompts new cancer treatments GlobalData
19-Dec-2019 David Hale appointed CEO of Guerbet as from January 1, 2020 to accelerate deployment of the Group's strategy Guerbet
19-Dec-2019 Median Technologies announces the signing of a € 35 million finance contract with the European Investment Bank (EIB) Median Technologies
19-Dec-2019 Sartorius Establishes Scientific Advisory Board The Sartorius Group
19-Dec-2019 Parkinson’s symptoms are improved with weekly regimens that include physical and cognitive exercises The Physiological Society
19-Dec-2019 Phoenix Solutions Enters Clinical Phase The Institute of Cancer Research